Bristol Myers Squibb Expands Patient Support Programs to Help Newly Uninsured Patients in the U.S.

The global spread of COVID-19 is affecting each of us and the communities in which we live in different ways. Bristol Myers Squibb recognizes this is a challenging time for everyone. We are focused on protecting the health and safety of our workforce, ensuring there is no disruption to the supply of our medicines to patients and supporting relief efforts across the globe. As a responsible global citizen, we will take all necessary actions to promote public health and carry out our mission of providing life-saving medicines to the patients who depend on us.  Please see the attached PDF for more information on the expansion of our existing patient support programs to help eligible unemployed patients in the U.S. who have lost their health insurance due to the COVID-19 pandemic.

Learn more in the press release.